NICE Approval For rTMS Depression Treatment

The National Institute for Health and Care Excellence (NICE) in the UK has now approved rTMS (Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK.

NICE Approves rTMS for Depression

The guidelines issued by NICE have not specified or restricted the type of rTMS treatment, which means that practitioners can offer treatment using conventional rTMS – which takes around 40 minutes per session – and/or theta burst, which takes around 5 minutes.

Repetitive Transcranial Magnetic Stimulation is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood.

The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants.

rTMS has also been shown effective in treating migraine, post-natal depression and pain

Ectron are the UK exclusive distributors of Magventure's rTMS system known as Magvita. This is the only system that has been awarded a CE mark for clinical use.

rTMS treatment is now available from SmartTMS

read more about the approval at: NICE GUIDELINES